Which potential side effect is associated with systemic antifungals for tinea infections?

The correct choice is associated with hepatotoxicity, which is a known risk for patients receiving systemic antifungals for tinea infections. Medications such as terbinafine and itraconazole, commonly used for these infections, can affect liver function and possibly lead to liver damage. This can manifest as elevated liver enzymes in blood tests, and in severe cases, it can result in acute liver injury.

Monitoring liver function tests is crucial during treatment with systemic antifungals, especially for patients with pre-existing liver conditions or those taking other medications that could exacerbate liver toxicity. Recognizing hepatotoxicity is essential in managing treatment safely and effectively, guiding decisions on whether to continue or adjust therapy based on liver function status.

Other potential side effects, while they may be associated with other types of medications or conditions, do not directly relate to the profile of systemic antifungals used specifically for tinea infections in the same way that hepatotoxicity does.